GNI Group Ltd. (2160.T)
JPY 2237.0
(1.68%)
JPY 2237.0
(1.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -17.93 Billion JPY | -70.6% |
| 2022 | -10.51 Billion JPY | 20.52% |
| 2021 | -13.22 Billion JPY | -54.22% |
| 2020 | -8.57 Billion JPY | -52.16% |
| 2019 | -5.63 Billion JPY | -122.11% |
| 2018 | -2.53 Billion JPY | 11.6% |
| 2017 | -2.87 Billion JPY | -49.47% |
| 2016 | -1.92 Billion JPY | 18.09% |
| 2015 | -2.34 Billion JPY | 47.2% |
| 2014 | -4.44 Billion JPY | -45.09% |
| 2013 | -3.06 Billion JPY | -572.62% |
| 2012 | -455.02 Million JPY | 13.97% |
| 2011 | -528.9 Million JPY | 4.68% |
| 2010 | -554.89 Million JPY | 0.0% |
| 2008 | -451.57 Million JPY | 65.76% |
| 2007 | -1.31 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -14.1 Billion JPY | 21.33% |
| 2024 Q2 | -10.28 Billion JPY | 27.09% |
| 2023 Q1 | -10.1 Billion JPY | 3.89% |
| 2023 Q4 | -17.93 Billion JPY | -8.22% |
| 2023 Q3 | -16.57 Billion JPY | -29.77% |
| 2023 Q2 | -12.77 Billion JPY | -26.41% |
| 2023 FY | -17.93 Billion JPY | -70.6% |
| 2022 Q3 | -11.83 Billion JPY | 12.63% |
| 2022 Q4 | -10.51 Billion JPY | 11.16% |
| 2022 FY | -10.51 Billion JPY | 20.52% |
| 2022 Q1 | -13.96 Billion JPY | -5.57% |
| 2022 Q2 | -13.54 Billion JPY | 3.01% |
| 2021 Q1 | -12.07 Billion JPY | -40.78% |
| 2021 Q3 | -12.61 Billion JPY | 1.25% |
| 2021 Q4 | -13.22 Billion JPY | -4.86% |
| 2021 FY | -13.22 Billion JPY | -54.22% |
| 2021 Q2 | -12.77 Billion JPY | -5.78% |
| 2020 Q3 | -6.4 Billion JPY | -5.59% |
| 2020 Q2 | -6.06 Billion JPY | -1.88% |
| 2020 FY | -8.57 Billion JPY | -52.16% |
| 2020 Q4 | -8.57 Billion JPY | -33.86% |
| 2020 Q1 | -5.95 Billion JPY | -5.67% |
| 2019 Q1 | -2.2 Billion JPY | 13.12% |
| 2019 FY | -5.63 Billion JPY | -122.11% |
| 2019 Q4 | -5.63 Billion JPY | -11.88% |
| 2019 Q3 | -5.03 Billion JPY | -30.08% |
| 2019 Q2 | -3.87 Billion JPY | -75.65% |
| 2018 Q4 | -2.53 Billion JPY | -1.03% |
| 2018 Q2 | -2.64 Billion JPY | 12.08% |
| 2018 FY | -2.53 Billion JPY | 11.6% |
| 2018 Q3 | -2.51 Billion JPY | 5.1% |
| 2018 Q1 | -3.01 Billion JPY | -4.86% |
| 2017 Q1 | -1.5 Billion JPY | 21.4% |
| 2017 Q4 | -2.87 Billion JPY | 4.06% |
| 2017 FY | -2.87 Billion JPY | -49.47% |
| 2017 Q3 | -2.99 Billion JPY | 60.68% |
| 2017 Q2 | -7.6 Billion JPY | -404.05% |
| 2016 Q2 | -2.06 Billion JPY | -1.12% |
| 2016 Q4 | -1.92 Billion JPY | 1.79% |
| 2016 Q3 | -1.95 Billion JPY | 5.52% |
| 2016 FY | -1.92 Billion JPY | 18.09% |
| 2016 Q1 | -2.04 Billion JPY | 12.7% |
| 2015 FY | -2.34 Billion JPY | 47.2% |
| 2015 Q3 | -3.02 Billion JPY | 4.57% |
| 2015 Q2 | -3.17 Billion JPY | 5.06% |
| 2015 Q1 | -3.33 Billion JPY | 24.8% |
| 2015 Q4 | -2.34 Billion JPY | 22.51% |
| 2014 FY | -4.44 Billion JPY | -45.09% |
| 2014 Q2 | -4.71 Billion JPY | 3.09% |
| 2014 Q4 | -4.44 Billion JPY | -1.89% |
| 2014 Q3 | -4.35 Billion JPY | 7.6% |
| 2014 Q1 | -4.86 Billion JPY | -59.03% |
| 2013 Q2 | -762.61 Million JPY | -105.56% |
| 2013 Q3 | -375.28 Million JPY | 50.79% |
| 2013 FY | -3.06 Billion JPY | -572.62% |
| 2013 Q4 | -3.06 Billion JPY | -715.54% |
| 2013 Q1 | -370.99 Million JPY | 18.47% |
| 2012 FY | -455.02 Million JPY | 13.97% |
| 2012 Q1 | -761 Million JPY | -43.88% |
| 2012 Q2 | -673.67 Million JPY | 11.48% |
| 2012 Q3 | -573.73 Million JPY | 14.83% |
| 2012 Q4 | -455.02 Million JPY | 20.69% |
| 2011 Q2 | -613.37 Million JPY | 10.1% |
| 2011 Q4 | -528.9 Million JPY | -130.75% |
| 2011 FY | -528.9 Million JPY | 4.68% |
| 2011 Q3 | -229.2 Million JPY | 62.63% |
| 2011 Q1 | -682.31 Million JPY | -22.96% |
| 2010 Q1 | -640.66 Million JPY | 0.0% |
| 2010 FY | -554.89 Million JPY | 0.0% |
| 2010 Q3 | -498.71 Million JPY | 13.18% |
| 2010 Q2 | -574.44 Million JPY | 10.34% |
| 2010 Q4 | -554.89 Million JPY | -11.27% |
| 2009 Q3 | -290.67 Million JPY | 22.22% |
| 2009 Q2 | -373.7 Million JPY | 17.24% |
| 2009 Q1 | -451.57 Million JPY | 24.76% |
| 2008 FY | -451.57 Million JPY | 65.76% |
| 2008 Q4 | -600.17 Million JPY | 0.0% |
| 2007 FY | -1.31 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 2514.457% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -1481.525% |
| Linical Co., Ltd. | -4.46 Billion JPY | -301.802% |
| Trans Genic Inc. | -221.16 Million JPY | -8008.548% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | -308.136% |
| Soiken Holdings Inc. | -4.79 Billion JPY | -274.395% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 1351.003% |
| AnGes, Inc. | -3.79 Billion JPY | -372.216% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -4161.715% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 171.999% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -3500.01% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -3745.547% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | -562.703% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -849.772% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -1725.968% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | -427.921% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -1633.461% |
| Kidswell Bio Corporation | 343.58 Million JPY | 5319.49% |
| PeptiDream Inc. | 3.29 Billion JPY | 644.764% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -1743.895% |
| Ribomic Inc. | -2.09 Billion JPY | -754.085% |
| SanBio Company Limited | -3.78 Billion JPY | -373.217% |
| Healios K.K. | -2.19 Billion JPY | -718.886% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -1798.016% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | -583.407% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -1165.548% |
| StemRIM | -8.41 Billion JPY | -113.241% |
| CellSource Co., Ltd. | -4.68 Billion JPY | -282.912% |
| FunPep Company Limited | -1.79 Billion JPY | -899.99% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -739.395% |
| Stella Pharma Corporation | -1.11 Billion JPY | -1502.066% |
| TMS Co., Ltd. | -3.44 Billion JPY | -420.323% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | -222.797% |
| Cuorips Inc. | -5.56 Billion JPY | -222.488% |
| K Pharma,Inc. | -3.26 Billion JPY | -449.031% |
| Takara Bio Inc. | -32.2 Billion JPY | 44.311% |
| ReproCELL Incorporated | -2.93 Billion JPY | -510.182% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -2613.265% |
| StemCell Institute Inc. | -2.83 Billion JPY | -532.187% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -767.89% |
| CellSeed Inc. | -2.01 Billion JPY | -791.313% |